Androstanolone is available in pharmaceutical formulations for medical use as an androgen.It was discovered in 1935 and was introduced for medical use in 1953.It is also used to treat breast development and small penis in males. Reference standards of Androstanolone API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Androstanolone
Catalogue No.:PA 01 58000
CAS :
Molecular Formula : C19H30O2
Molecular Weight : 290.44
Androstenone
Catalogue No.:PA 01 58510
Molecular Formula : C19H28O
Molecular Weight : 272.43
Dihydrotestosterone Tridecanoate-d3
Catalogue No.:PA STI 032950
Molecular Formula : C32H51D3O3
Molecular Weight : 489.79
3-O-Acetylandrostenone hydrazone
Catalogue No.:PA 01 0581000
Molecular Formula : C21H32N2O2
Molecular Weight : 344.5
(5R,8R,9S,10S,13S,14S,17S)-10,13-Dimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoate
Catalogue No.:PA 01 0581001
Molecular Formula : C26H42O3
Molecular Weight : 402.62
5α-Androstan-3β-ol
Catalogue No.:PA 01 0581002
Molecular Formula : C19H32O
Molecular Weight : 276.46
1,4,6-Androstatriene-3,17-dione
Catalogue No.:PA 01 0581003
Molecular Formula : C19H22O2
Molecular Weight : 282.38
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
